Slide background
Origin Capital

Origin Capital

Origin invests in early-stage unquoted businesses and smaller quoted companies. Most of Origin's portfolio companies have a technology focus, for example high-value manufacturing, life sciences, software and IT infrastructure with nvestment transactions typically of £50k – £2m.
Pfizer

Pfizer

Pfizer Pfizer is a global pharma seeking to new opportunities in many areas including the early stage space.
Rx Securities

Rx Securities

Rx Securities is Europe's only full service, investment bank dedicated solely to the healthcare sector and serving both institutional investors and life science companies.
Sanofi

Sanofi

Sanofi leverages new biotechnologies to more effectively target disease pathways and bring breakthrough medicines to patients faster. Part of our innovation effort relies on a variety of different partnering models with external specialists to access early stage and cutting-edge technologies and new innovation. BioSeed offers an opportunity to meet innovative companies in our areas of interest that we have not met before.
SR One

SR One

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care.
Sygnature Discovery

Sygnature Discovery

Sygnature Discovery is a private equity-backed drug discovery company. We work with our partners via flexible deal structures from company formation, through seed funding to Series A. Recent investments include Peak Proteins, a protein crystallography company, and Step Pharma, an auto-immune diseases-focused biotechnology company. As well as investing itself, Sygnature works with universities and biotech start-ups to raise funds from non-dilutive sources and venture capital companies.
SyndicateRoom

SyndicateRoom

SyndicateRoom connects ambitious investors with the country’s most trailblazing companie

Tim Mustill

Tim is an angel investor and a highly experienced and extremely well-connected pharmaceutical industry executive with a wide range of skills and expertise in commercial strategy, marketing and medical affairs.
Vita Advisory

Vita Advisory

Vita Advisory operate a venture capital and growth fund dedicated to life sciences.
Waimangu Ventures

Waimangu Ventures

Waimangu is building a venture capital fund to invest in early stage healthcare and technology companies focussed on London and the South East of the UK
Wellington Partners

Wellington Partners

Wellington Partners is a leading European VC investing in early- and growth-stage life science companies.